Document is current
Any future updates will be listed below
-
Authors
Yamamoto, Kenta https://orcid.org/0000-0003-0203-8603
Kishida, Tsunao
Yamamoto, Toshiro
Sowa, Yoshihiro
Seki, Makoto
Mazda, Osam
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (24K02627, 24K22195, 21K19577, 21H03058, 21K09937)
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 19 August 2025
First Online: 30 October 2025
Declarations
:
: All animal experiments were approved by Animal Experiment Committee of Kyoto Prefectural University of Medicine, and all animal care was provided in accordance with the institutional guidelines. (Title: Analysis of functions and in vivo kinetics for induced cells in inflammatory disease model., Number: M2022-526, Approved on June, 29th, 2022). The original sources of the cells we used in this study (Lonza, LifeLine Cell Technologies, KURABO and Cellular Engineering Technologies) have confirmed that there was initial ethical approval for collection of human primary cells, and that the donors had signed informed consent. The authors declare that they have not use AI-generated work in this manuscript.
: Not applicable.
: This research is financially supported in part by the CellAxia Inc. which Makoto Seki belongs to.
